Cheng, Christopher J.
Verve Therapeutics (United States)
3 papers on CoChatORCID 0009-0008-8092-5199
Most cited papers
- Verified
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Musunuru, K., Chadwick, A. C., Mizoguchi, T., Garcia, S. P., DeNizio, J. E., Reiss, C. W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., et al. (2021) · Nature
CRISPR and Genetic EngineeringLipoproteins and Cardiovascular Health
Cited by 793
- Verified
A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery
Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems
Cited by 480
- Verified
Sustained delivery of proangiogenic microRNA‐132 by nanoparticle transfection improves endothelial cell transplantation
Devalliere, J., Chang, W. G., Andrejecsk, J. W., Abrahimi, P., Cheng, C. J., Jane‐wit, D., Saltzman, W. M., & Pober, J. S. (2014) · The FASEB Journal
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 83
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free